Published Date: 28 Mar 2025
The increasing number of people with eating disorders and a lack of national guidance for support teams has led to researchers calling for a new national strategy that includes specific guidance to support the remote delivery ...
Read Full NewsEmerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice
Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk
As we embrace the power of collective knowledge, we must remember that numbers are just numbers
News, features, and commentary about cancer-related issues
News, features, and commentary about cancer-related issues
"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said
Improvements primarily driven by reduction in incidence of relapse
1.
Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.
2.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
3.
GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer
4.
Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.
5.
In Acute Leukemia With Heavily Pretreated Patients, Menin Inhibitor Yields 63 Percent ORR.
1.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
2.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
3.
Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions
4.
Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management
5.
Fc Receptor Mediated Pharmacology of Therapeutic Antibodies
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
2.
Oropharyngeal Cancer in Relation to HPV Status
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation